Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News China Pharma Holdings Inc CPHI

China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables... see more

Recent & Breaking News (NYSEAM:CPHI)

China Pharma Holdings, Inc. Reports Second Quarter 2013 Financial Results

PR Newswire August 15, 2013

CPHI to Hold Second Quarter of Fiscal Year 2013 Earnings Conference Call on Thursday, August 15, 2013 at 8:30 a.m. ET

PR Newswire August 1, 2013

China Pharma Holdings, Inc. Reports First Quarter 2013 Financial Results

PR Newswire May 15, 2013

CPHI to Hold First Quarter of Fiscal Year 2013 Earnings Conference Call on Wednesday, May 15, 2013 at 8:30 a.m. ET

PR Newswire May 6, 2013

China Pharma Holdings, Inc. Reports Full Year 2012 Financial Results

PR Newswire March 15, 2013

CPHI to Hold Fiscal Year 2012 Earnings Conference Call on Friday, March 15, 2013 at 8:30 a.m. ET

PR Newswire March 5, 2013